FIELD: biochemistry.
SUBSTANCE: invention relates to production of iodized whey proteins for preparing a biologically active substance and can be used for preventing iodine deficiency disorders in humans and animals. Process of iodination of initial protein raw material, in form of α-lactalbumin, β-lactoglobulin or a mixture of said proteins, or hydrolysates of said proteins, by mixing with an aqueous solution of inorganic iodine at temperature of 20–40 °C and at ratio of solution of inorganic iodine to total protein selected (2–40):1. Mixture of whey proteins is fermented with an aqueous solution of inorganic iodine by adding a buffer mixture of reagents – a complex of NaCl mineral salts and Na and K phosphates and a mixture of lactoperoxidase-based enzymes containing 16–24 wt%, horseradish peroxidase and from 14 to 21 wt% of catalase. Buffer mixture contains 14–18 wt% sodium phosphate and 22–28 wt% potassium orthophosphate with stability pH=6–8 with a reaction mixture of enzymes immobilized on semi-permeable membranes or on inert carriers. Fermentation process is carried out with continuous monitoring of iodine content in the solution. Aqueous solution of iodinated proteins is purified from macroimpurities and microimpurities, including from inorganic iodine, using macrofiltration, microfiltration with subsequent diafiltration of aqueous solution of iodinated proteins on ultrafiltration unit in tangential flow mode using membrane modules with cut-off limit of 300 to 800 Da at pH 6.0–8.0. Obtained solution of iodated proteins subject to sterilizing microfiltration, then sublimation or spray drying to obtain a finished powder product with content of deterministic covalently bound iodine in amount of 0.5–4 % in form of a mixture of iodised amino acids – monoiodotyrosines in amount of 55–75 wt% in iodated proteins, 24.0–43.5 wt% di-iodotyrosines and 1.0–1.5 wt% of tri-iodotyrosines.
EFFECT: invention enables to obtain a ready powder product with given content of deterministic amount of covalently bound iodine with optimal and specified content of iodised amino acids in it – monoiodotyrosines, di-iodotyrosines and tri-iodotyrosines, production of industrial volumes of iodized milk whey proteins.
1 cl, 6 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF PRODUCING IODINATED MICELLAR CASEIN SUITABLE FOR USE IN FORMULATIONS OF PHARMACOLOGICAL AND VETERINARY PREPARATIONS, BIOLOGICALLY ACTIVE ADDITIVES AND RADIOPROTECTIVE PREPARATIONS, COMPOSITION FOR PREVENTING IODINE DEFICIENCY AND OPTIMIZING IODINE METABOLISM, COMPOSITION FOR PREVENTING AND PROTECTING AGAINST RADIATION DAMAGE | 2024 |
|
RU2826384C1 |
METHOD OF OBTAINING BIOLOGICALLY ACTIVE FOOD ADDITIVE | 2002 |
|
RU2212155C1 |
COMPLEX ADDITIVE WITH BIOLOGICALLY ACTIVE PROPERTIES FOR BAKERY PRODUCTS BASED ON SOYA DRINK AND\OR SOYA OKARA AND PRODUCT THAT CONTAINS IT | 2006 |
|
RU2356246C2 |
METHOD FOR COMPLEX PROCESSING AGRICULTURAL ANIMALS BLOOD FOR PREPARING HEMOGLOBIN-BASE BIOLOGICALLY ACTIVE SUBSTANCE WITH ANTI-ANEMIC PROPERTIES, BIOLOGICALLY ACTIVE SUBSTANCE WITH ANTI-ANEMIC PROPERTIES (VARIANTS) AND PRODUCT COMPRISING THEREOF (VARIANTS) | 2004 |
|
RU2274003C2 |
MILK PROCESSING METHOD AND PRODUCT PRODUCED BY THIS METHOD | 2012 |
|
RU2535876C2 |
PRODUCTION METHOD OF BIOLOGICALLY ACTIVE FOOD ADDITIVE TO PREVENT IODEIN DEFICIENCY | 2008 |
|
RU2380984C1 |
METHOD OF PREVENTION OF LESIONS CAUSED BY IODIN RADIONUCLIDES AND OPTIMISATION OF IODIN METABOLISM IN POST-PREVENTIVE PERIOD | 2002 |
|
RU2323733C2 |
BIOLOGICALLY ACTIVE FOOD ADDITIVE CONTAINING NON-IONIC FORMS OF IODINE AND SELENIUM | 2021 |
|
RU2765999C1 |
IODINE-CONTAINING BIOLOGICALLY ACTIVE ADDITIVE | 2006 |
|
RU2321274C2 |
METHOD FOR PRODUCING A BACTERIOLOGICALLY PURE PROTEIN PRODUCT WITH HIGH CONTENT OF MINOR PROTEINS | 2020 |
|
RU2736645C1 |
Authors
Dates
2019-09-17—Published
2019-06-14—Filed